Hexavest Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 8 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Hexavest Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2019$20,0000.0%1,1340.0%0.00%
Q2 2019$20,000
-13.0%
1,1340.0%0.00%
Q1 2019$23,000
+21.1%
1,1340.0%0.00%
Q4 2018$19,000
-20.8%
1,1340.0%0.00%
Q3 2018$24,0000.0%1,1340.0%0.00%
Q2 2018$24,000
-14.3%
1,1340.0%0.00%
Q1 2018$28,000
-12.5%
1,1340.0%0.00%
Q4 2017$32,000
+3.2%
1,1340.0%0.00%
Q3 2017$31,000
+6.9%
1,1340.0%0.00%
Q2 2017$29,000
+7.4%
1,1340.0%0.00%
Q1 2017$27,000
+12.5%
1,1340.0%0.00%
Q4 2016$24,000
-11.1%
1,1340.0%0.00%
Q3 2016$27,000
+12.5%
1,1340.0%0.00%
Q2 2016$24,000
-7.7%
1,1340.0%0.00%
Q1 2016$26,000
-7.1%
1,1340.0%0.00%
Q4 2015$28,000
+12.0%
1,1340.0%0.00%
Q3 2015$25,000
-7.4%
1,1340.0%0.00%
Q2 2015$27,000
-3.6%
1,1340.0%0.00%
Q1 2015$28,000
+16.7%
1,1340.0%0.00%
Q4 2014$24,000
-4.0%
1,1340.0%0.00%
Q3 2014$25,000
-3.8%
1,1340.0%0.00%
Q2 2014$26,000
-3.7%
1,1340.0%0.00%
Q1 2014$27,000
+3.8%
1,1340.0%0.00%
Q4 2013$26,000
-3.7%
1,1340.0%0.00%
Q3 2013$27,000
+3.8%
1,1340.0%0.00%
Q2 2013$26,0001,1340.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2017
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders